Efficacy and safety of nitazoxanide in treating SARS-CoV-2 infection: a systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials

PURPOSE: Nitazoxanide is a broad-spectrum antiparasitic that has been tested for COVID-19 due to its anti-inflammatory effects and in vitro antiviral activity. This study synthesized the best evidence on the efficacy and safety of nitazoxanide in COVID-19. METHODS: Searches for studies were performe...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins-Filho, Paulo Ricardo, do Nascimento-Júnior, Edmundo Marques, Barreto-Alves, José Antônio, Fakhouri, Ricardo, Ferreira, Lis Campos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446612/
https://www.ncbi.nlm.nih.gov/pubmed/36066651
http://dx.doi.org/10.1007/s00228-022-03380-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446612/
https://www.ncbi.nlm.nih.gov/pubmed/36066651
http://dx.doi.org/10.1007/s00228-022-03380-5

Ejemplares similares